Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells

Cellular Microbiology

Volumn 9, Issue 8, 2007, Pages 2030-2039

  Triantafilou, Martha ^a   Gamper, Frederick G J ^a   Lepper, Philipp M ^b,c   Mouratis, Marios Angelos ^a   Schumann, Christian ^c   Harokopakis, Evlambia ^d   Schifferle, Robert E ^e   Hajishengallis, George ^d   Triantafilou, Kathy ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF ULM   (Germany)

^d University of Louisville School of Medicine   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD11B ANTIGEN; CD18 ANTIGEN; CD36 ANTIGEN; CYTOKINE; PATTERN RECOGNITION RECEPTOR; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTIGEN RECOGNITION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIUM; CELL ACTIVATION; CELL STRAIN HEK293; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; LIPID RAFT; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; RNA INTERFERENCE; VASCULAR ENDOTHELIUM;

ANTIGENS, CD11B; ANTIGENS, CD18; ANTIGENS, CD36; ATHEROSCLEROSIS; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HELICOBACTER PYLORI; HUMANS; LIPOPOLYSACCHARIDES; MEMBRANE MICRODOMAINS; PORPHYROMONAS GINGIVALIS; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS); CHLAMYDIA; HELICOBACTER PYLORI; PORPHYROMONAS GINGIVALIS;

EID: 34447627336     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2007.00935.x     Document Type: Article

References (48)

1. Akira, S. (2001) Toll-like receptors and innate immunity. Adv Immunol 78: 1-56.
2. Bastiaens, P.I., Majoul, I.V., Verveer, P.J., Soling, H.D., and Jovin, T.M. (1996) Imaging the intracellular trafficking and state of the AB5 quaternary structure of cholera toxin. EMBO J 15: 4246-4253.
3. Bjorkbacka, H., Kunjathoor, V.V., Moore, K.J., Koehn, S., Ordija, C.M., Lee, M.A., et al. (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10: 416-421.
4. Coats, S.R., Reife, R.A., Bainbridge, B.W., Pham, T.T., and Darveau, R.P. (2003) Porphyromonas gingivalis lipopolysaccharide antagonises Escherichia coli lipopolysaccharide at Toll-like receptor 4 in human endothelial cells. Infect Immun 71: 6799-6807.
5. Danesh, J., Collins, R., and Peto, R. (1997) Chronic infections and coronary heart disease: Is there a link? Lancet 350: 430-436.
6. Danesh, J., Wong, Y., Ward, M., and Muir, J. (1999) Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease. Heart 81: 245-247.
7. Dixon, D.R., and Darveau, R.P. (2005) Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J Dent Res 84: 584-595.
8. Edfeldt, K., Swedenborg, J., Hansson, G.K., and Yan, Z.Q. (2002) Expression of Toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation 105: 1158-1161.
9. Frantz, S., Kobzik, L., Kim, Y.D., Fukazawa, R., Medzhitov, R., Lee, R.T., and Kelly, R.A. (1999) Toll 4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104: 271-280.
10. Gibson, F.C., III, Yumoto, H., Takahashi, Y., Chou, H.H., and Genco, C.A. (2006) Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J Dent Res 85: 106-121.
11. Grayston, J.T. (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181: S402-S410.
12. Hajishengallis, G., Sharma, A., Russell, M.W., and Genco, R.J. (2002a) Interactions of oral pathogens with Toll-like receptors: Possible role in atherosclerosis. Ann Periodontol 7: 72-78.
13. Hajishengallis, G., Martin, M., Schifferle, R.E., and Genco, R.J. (2002b) Counteracting interactions between lipopolysaccharide molecules with differential activation of Toll-like receptors. Infect Immun 70: 6658-6664.
14. Hajishengallis, G., Ratti, P., and Harokopakis, E. (2005) Peptide mapping of bacterial fimbrial epitopes interacting with pattern recognition receptors. J Biol Chem 280: 38902-38913.
15. Hansson, G.K. (2001) Immune mechanisms in atherosclerosis. Arterioscler Thomb Vasc Biol 21: 1876-1890.
16. Hansson, G.K., Libby, P., Schonbeck, U., and Yan, Z.Q. (2002) Innate and adaptive immunity in the pahtogenesis of atherosclerosis. Circ Res 91: 281-291.
17. Hirschfeld, M., Ma, Y., Weis, J.H., Vogel, S.N., and Weis, J.J. (2000) Repurification of lipopolysaccharide eliminates signalling through both human and murine Toll-like receptor 2. J Immunol 165: 618-622.
18. Hirschfeld, M., Weis, J.J., Toshchakov, V., Salkowski, C.A., Cody, M.J., Watts, D.C., et al. (2001) Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69: 1477-1482.
19. Hoebe, K., Georgel, P., Du Rutschmann, S.X., Mudd, S., Crozat, K., Sovath, S., et al. (2005) CD36 is a sensor of diacylglycerides. Nature 433: 523-527.
20. Hubacek, J.A., Pitha, J., Skodova, Z., Stanek, V., and Poledne, R. (1999) C (-260) T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99: 3218-3220.
21. Kenworthy, A.K., and Edidin, M. (1998) Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of < 100 A using imaging fluorescence resonance energy transfer. J Cell Biol 142: 69-84.
22. Kiechl, S., Egger, G., Mayr, M., Wiedermann, C.J., Bonora, E., Oberhollenzer, F., et al. (2001) Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study. Circulation 103: 1064-1070.
23. Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C.J., Oberhollenzer, F., Bonora, E., et al. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347: 185-192.
24. Kuo, C., Grayston, J.T., Campbell, L.A., and Goo, Y.A. (1995) Chlamydia pneumoniae in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 92: 6911-6914.
25. Lehr, H.A., Sagban, T.A., Ihling, C., Zahringer, U., Hungerer, K.D., Blumrich, M., et al. (2001) Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 104: 914-920.
26. Leitersdorf, E., Tobin, E.J., Davignon, J., and Hobbs, H.H. (1990) Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 85: 1014-1023.
27. Lepper, P.M., Triantafilou, M., Schumann, C., Schneider, E.M., and Triantafilou, K. (2005) Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4. Cell Microbiol 7: 519-528.
28. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420: 868-874.
29. Libby, P., Ridker, P.M., and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
30. Loppnow, H., Rietschel, E., Brade, H., Schonbeck, U., Libby, P., Wang, M.H., et al. (1993) Lipid A Precursor La (Compound 406) and Rhodobacter Capsulatus Lipopolysaccharide: A Potent Endotoxin Antagonists in the Human System in Vitro. Amsterdam: Elsevier.
31. Malek, R., Fisher, J.G., Caleca, A., Stinson, M., van Oss, C.J., Lee, J.Y., et al. (1994) Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol 176: 1052-1059.
32. Manthey, C.L., and Vogel, S.N. (1994) Elimination of trace endotoxin protein from rough chemotype LPS. J Endotoxin Res 1: 84-90.
33. Mayr, M., Kiechl, S., Willeit, J., Wick, G., and Xu, Q. (2000) Infections, immunity, and atherosclerosis: Associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat shock protein 60 and carotid and femoral atherosclerosis. Circulation 102: 833-839.
34. Michelsen, K.S., Wong, M.H., Shah, P.K., Zhang, W., Yano, J., Doherty, T.M., et al. (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101: 10679-10684.
35. Mullaly, S.C., and Kubes, P. (2004) Toll gates and traffic arteries. Circ Res 95: 657-659.
36. Rose, J.R., Christ, W.J., Bristol, J.R., Kawata, T., and Rossignol, D.P. (1995) Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: Comparison with activities of synthetic material of the proposed structure and analogs. Infect Immun 63: 833-839.
37. Ross, R. (1999) Atherosclerosis: An inflammatory disease. N Engl J Med 340: 115-126.
38. Roth, G.A., Moser, B., Roth-Walter, F., Giacona, M.B., Harja, E., Papapanou, P.N., et al. (2006) Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis 190: 271-281.
39. Schumacher, A., Seljeflot, I., Lerkerod, A.B., Sommervoll, L., Otterstad, J.E., and Arnesen, H. (2002) Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis 164: 153-160.
40. Triantafilou, K., Triantafilou, M., and Dedrick, R.L. (2001) A CD14-independent LPS receptor cluster. Nat Immunol 4: 338-345.
41. Triantafilou, M., Miyake, K., Golenbock, D., and Triantafilou, K. (2002) Mediators of the innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115: 2603-2611.
42. Triantafilou, M., Brandenburg, K., Kusumoto, S., Fukase, K., Mackie, A., Seydel, U., and Triantafilou, K. (2004a) Combinational clustering of receptors following stimulation by bacterial products determines LPS responses. Biochem J 381: 527-536.
43. Triantafilou, M., Morath, S., Mackie, A., Hartung, T., and Triantafilou, K. (2004b) Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 117: 4007-4014.
44. Visintin, A., Latz, E., Monks, B.G., Espevik, T., and Golenbock, D.T. (2003) Lysines 128 and 132 enable lipopolysaccharide binding to MD2, leading to Toll-like receptor 4-aggregation and signal transduction. J Biol Chem 278: 48313-48320.
45. Wang, P.Y., Kitchens, R., and Munford, R.S. (1996) Bacterial lipopolysaccharide binds to CD14 in low density domains of the monocyte-macrophage plasma membrane. J Inflamm 47: 126-137.
46. Westphal, O., and Jann, K. (1965) Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 25: 83-91.
47. Yoshimura, A., Kaneko, T., Kato, Y., Golenbock, D.T., and Hara, Y. (2002) Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human Toll-like receptor 4. Infect Immun 70: 218-225.
48. Zeuke, S., Ulmer, A.J., Kusumoto, S., Katus, H.A., and Heine, H. (2002) TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res 56: 126-134.